en

PRODUCT DETAIL

Bosentan Cipla 62,5 mg filmom obalené tablety

Code 9831B
MA number 58/0307/16-S
Product Form: tbl flm 14x1x62,5 mg (blis.PVC/PE/PVDC/Al-jednotliv.dávka)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
MAH, country: Cipla Europe NV, Belgium
Therapeutic Class: 58 - HYPOTENSIVA
ATC:
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02K OTHER ANTIHYPERTENSIVES
C02KX Antihypertensives for pulmonary arterial hypertension
C02KX01 Bosentan
Shelf life: 24
Container: blister PVC/PE/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 15.06.2016
Pediatric posology: Yes
SPC: SPC_Bosentan Cipla 125 mg_tbl flm_10_2024.pdf  
PIL: PIL_Bosentan Cipla 125 mg_tbl flm_10_2024.pdf  
Safety feature Yes
Data update: 14.12.2020
eu-flag.png sk-flag.png